The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear
NCT02435368 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10
Last updated 2015-05-06
Summary
To determine the mechanisms and significances of synergistic effects of mycophenolic acid and LPS on IL-1β secretion by mononuclear
Conditions
Interventions
- DRUG
-
mycophenolic acid
Monocytes were co-cultured with LPS and/or MPA.After 12 hours, the supernatants were harvested and stored at -80°C for ELISA.
Sponsors & Collaborators
-
The Third Affiliated Hospital of Southern Medical University
lead OTHER_GOV
Principal Investigators
-
erwei Sun, doctor · Third Affiliated Hospital of Southern Medical University
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-04-30
- Primary Completion
- 2015-11-30
- Completion
- 2016-03-31
Countries
- China
Study Locations
More Related Trials
-
Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis
NCT02630628 ·Status: COMPLETED ·Phase: PHASE3
-
Exploring Biomarkers for Therapeutic Response of Lupus Nephritis Based on Multi Omics Analysis
NCT06167174 ·Status: RECRUITING
-
Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis
NCT00371319 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis
NCT02954939 ·Status: RECRUITING ·Phase: NA
-
Induction Treatment of Proliferative Lupus Nephritis With Leflunomide Combined With Prednisone
NCT00268567 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Urine Exosomes to Identify Biomarkers for LN
NCT04894695 ·Status: UNKNOWN
-
Multicenter Registry of Pediatric Lupus Nephritis in China
NCT03791827 ·Status: UNKNOWN
-
Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare
NCT00423098 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis
NCT00404794 ·Status: COMPLETED ·Phase: PHASE3
-
Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg
NCT00705367 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase II Clinical Study on the Efficacy and Safety of SHR-2173 Injection in the Treatment of Patients With Active Lupus Nephritis
NCT07229742 ·Status: RECRUITING ·Phase: PHASE2
-
Comparison between2 Drugs in Lupus Nephritis
NCT04424602 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus
NCT05916781 ·Status: RECRUITING ·Phase: PHASE4
-
Low-dose IL-2( Interleukin-2) Treatment in SLE
NCT02084238 ·Status: COMPLETED ·Phase: NA
-
SSerum/Urinary Monocyte Chemoattractant Protein-1 Level as a Marker for Lupus Nephritis
NCT03164720 ·Status: UNKNOWN
-
Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study
NCT00429377 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
NCT05268289 ·Status: RECRUITING ·Phase: PHASE2
-
Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis
NCT00876616 ·Status: COMPLETED ·Phase: NA
-
A Pharmacoeconomic Study Comparing the Use of Mycophenolate Mofetil or Cyclophosphamide as Induction Therapy in Lupus Nephritis Patients in Egypt
NCT05195086 ·Status: COMPLETED
-
Concentration-controlled Therapy of Mycophenolate Mofetil (MMF) in Proliferative Lupus Nephritis
NCT01042457 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Evaluate the Safety and Effectiveness of BMS-986165 With Background Treatment in Participants With Lupus Nephritis
NCT03943147 ·Status: TERMINATED ·Phase: PHASE2
-
An Efficacy and Safety Study of CNTO 136 in Patients With Active Lupus Nephritis
NCT01273389 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE)
NCT04305197 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Leflunomide Versus Azathioprine for Maintenance Therapy of Lupus Nephritis
NCT01172002 ·Status: UNKNOWN ·Phase: NA
-
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment
NCT01689350 ·Status: COMPLETED ·Phase: NA